Evidence map›Paper›PMID 40830880›Full record

ArticleMolecular neurodegeneration2025

Correction: Clinical progression and genetic pathways in body-first and brain-first Parkinson's disease.

Massimiliano Passaretti, Daniel Veréb, Mite Mijalkov, Yu-Wei Chang, Hang Zhao, Blanca Zufiria-Gerbolés, Jiawei Sun, Giovanni Volpe, Natalia Rivera, Matteo Bologna and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Molecular neurodegeneration, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Massimiliano PassarettiDepartment of Clinical Neuroscience, Karolinska Institutet, K8 Klinisk neurovetenskap, K8 Neuro Pereira, 171 77, Stockholm, Sweden. massimiliano.passaretti@ki.se.ORCID http://orcid.org/0000-0002-7932-8695
Daniel VerébDepartment of Clinical Neuroscience, Karolinska Institutet, K8 Klinisk neurovetenskap, K8 Neuro Pereira, 171 77, Stockholm, Sweden.
Mite MijalkovDepartment of Clinical Neuroscience, Karolinska Institutet, K8 Klinisk neurovetenskap, K8 Neuro Pereira, 171 77, Stockholm, Sweden.
Yu-Wei ChangDepartment of Clinical Neuroscience, Karolinska Institutet, K8 Klinisk neurovetenskap, K8 Neuro Pereira, 171 77, Stockholm, Sweden.
Hang ZhaoDepartment of Clinical Neuroscience, Karolinska Institutet, K8 Klinisk neurovetenskap, K8 Neuro Pereira, 171 77, Stockholm, Sweden.
Blanca Zufiria-GerbolésDepartment of Clinical Neuroscience, Karolinska Institutet, K8 Klinisk neurovetenskap, K8 Neuro Pereira, 171 77, Stockholm, Sweden.
Jiawei SunDepartment of Clinical Neuroscience, Karolinska Institutet, K8 Klinisk neurovetenskap, K8 Neuro Pereira, 171 77, Stockholm, Sweden.
Giovanni VolpeDepartment of Physics, University of Gothenburg, Gothenburg, Sweden.
Natalia RiveraImmunology and Respiratory Medicine Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Karolinska University Hospital, Solna, Stockholm, Sweden.
Matteo BolognaDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Joana B PereiraDepartment of Clinical Neuroscience, Karolinska Institutet, K8 Klinisk neurovetenskap, K8 Neuro Pereira, 171 77, Stockholm, Sweden. joana.pereira@ki.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40830880
PMCPMC12366360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.